Search - tctmd.com

Displaying 201 - 220 of 332

Sort: Relevancy | Date

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

TOTAL Substudy: Routine Thrombectomy Has No Effect on Culprit Lesion Thrombus Burden in STEMI

L.A. McKeown

June 15, 2015

Presentation TVT 2015

NOTION in All-Comers

Presenter: Lars Sondergaard

June 05, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Yael L. Maxwell

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

L.A. McKeown

March 05, 2015

News Daily News

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

L.A. McKeown

February 26, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Conference News TCT 2014

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

September 17, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

News Industry News

New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

September 16, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

News Conference News TCT 2014

Post-procedural Consent in STEMI Trials Debated

September 15, 2014

News Industry News

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

September 15, 2014

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

Advertisement

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

COMPARE: EES Maintains Advantage Over PES at 5 Years

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

Method Chosen to Estimate Pre-PCI Kidney Function Matters

TOTAL Substudy: Routine Thrombectomy Has No Effect on Culprit Lesion Thrombus Burden in STEMI

NOTION in All-Comers

Trials Explore the Potential of Biodegradable-Polymer Stents

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Analysis of SYNTAX Patients Documents Underuse of OMT

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

Post-procedural Consent in STEMI Trials Debated

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content